Bronchiolitis in children: case study analysis

The case hands you the diagnosis — it says so in the stem — so the marks are not in getting to bronchiolitis. They are in the four vital signs and what you do about them. A respiratory rate of 58 in a 14-month-old is markedly tachypnoeic against a normal range in the mid-twenties to low thirties. Pronounced intercostal and subcostal retractions mean the child is recruiting accessory muscles to move air. A pulse oximetry reading of 96% is reassuring, and a temperature of 99.9 is barely a fever. And the mother reports decreased oral intake, with the child refusing to eat this morning. Two of those four are reassuring and two are not, which is exactly the judgement the assignment is testing. Say which is which, and say what would change your mind. A saturation of 96% on room air today does not commit you to 96% tomorrow, and bronchiolitis characteristically worsens through days three to five.

Take the hydration point seriously, because it is the one that most often decides disposition and the one students skim. An infant working this hard to breathe is spending calories on respiration while taking in less, and in bronchiolitis dehydration and feeding failure are far commoner reasons for admission than hypoxaemia. So "how will you treat this child" is not answerable without saying whether this child goes home, and what specifically would bring him back. Name the thresholds you would give the mother: work of breathing, wet nappy count, fluid volume taken, and any colour change or apnoea. That converts a treatment plan into a safety net, which is what the education question is separately asking for. The mother's own words are worth using here as well: she describes a sound like rice cereal popping, which is her account of coarse crackles, and reflecting that back in the education section is more likely to be understood than the clinical term.

Now the part that trips almost everyone. The prompt says: provide medication treatment and symptomatic care, provide correct medication dosage. For bronchiolitis the guideline-concordant answer is that there is essentially no pharmacological treatment, and the strong response says so explicitly rather than quietly supplying a salbutamol dose because the question seemed to ask for one. The 2014 American Academy of Pediatrics guideline recommends against bronchodilators — and does so regardless of a history of recurrent wheeze, atopy or family history of asthma, which is precisely the exemption most students try to claim from this mother's report of frequent colds. It also states that clinicians should not use chest physiotherapy. Note the shape of the answer that earns marks: you are not refusing to answer the question, you are answering it with a justified negative and then supplying the care that is indicated — suctioning, hydration, and oxygen only if it is needed.

There is a live complication worth one sentence, and including it is what separates current reading from a memorised 2014 position. A 2025 umbrella review in Pediatric Pulmonology pooled 21 meta-analyses — six on albuterol, four on epinephrine, eleven on hypertonic saline — and found that all three deimplemented medications show one or more therapeutic effects, with effect sizes ranging from medium to near-medium, including decreased hospital admissions and lower clinical severity scores. The authors call for therapeutic trials rather than for abandoning the guideline. So the defensible position is to follow the guideline and to know that its evidence base is contested, which is a more sophisticated answer than either reciting the prohibition or ignoring it. Handle it honestly in your post rather than as a hedge: cite the guideline as your practice standard, note that the evidence is under active re-examination, and say what would have to change before practice did.

The child's ethnicity is in the stem on purpose, and it belongs in your health promotion and socio-cultural sections rather than being noted and dropped. American Indian and Alaska Native children experience substantially higher rates of severe RSV disease, and at 14 months this patient falls into the second-RSV-season high-risk group for immunoprophylaxis rather than the routine first-season one. There is now direct evidence in this population: nirsevimab was 86.0% effective (95% CI 55.9–95.6) against RSV-associated hospitalisation among AI/AN children in their first season and 87.9% effective (95% CI 22.2–98.1) in their second, in a study across the Navajo Nation, White Mountain Apache tribal lands and Alaska. Which product and which dose applies depends on the current season's recommendations, so check them for the season your case sits in rather than reproducing last year's figures.

Be careful how you explain that risk, because the careless version is the mistake the socio-cultural question is watching for. The elevated risk is not a property of being Native American. It tracks social drivers of health — access to running water, distance and transport difficulty, household crowding and indoor air quality — which is why the same question that asks about barriers to your treatment plan is asking about the same variables. A plan that says "return immediately if breathing worsens" assumes a vehicle, a phone, and a clinic within reach. Saying what you would do if any of those are absent is the answer; attributing risk to ethnicity is not. The same logic runs through the immunisation answer: if the barrier to a well visit is a two-hour drive, then the anticipatory guidance that matters is which visits can be combined, not a recitation of the schedule.

Two smaller things the prompt names explicitly and posts routinely skip. It asks whether the case has addressed the LOCATES mnemonic, so walk it — location, other symptoms, character, aggravating factors, timing, environment, severity — and say which elements the stem leaves blank rather than asserting it is complete. And it asks for at least three differentials with the historical and physical features supporting each: the mother's report of frequent "bouts of colds" is a deliberate pull toward recurrent wheeze and asthma, and first-episode versus recurrent is the distinction your rationale should turn on, alongside pneumonia, foreign body aspiration and aspiration from reflux. Say explicitly which differential you are ruling out and on what basis, because the question asks for the features supporting your rationale and a list of names without evidence attached is the commonest way this section loses marks.